Online inquiry

IVTScrip™ mRNA-Human ATF7IP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26950MR)

This product GTTS-WK26950MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ATF7IP2 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001256160.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 80063
UniProt ID Q5U623
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ATF7IP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26950MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK20574MR IVTScrip™ mRNA-Human Androgen receptor, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA Androgen receptor
GTTS-WK15337MR IVTScrip™ mRNA-Human AIP, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA AIP
GTTS-WK12557MR IVTScrip™ mRNA-Human ADNP, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADNP
GTTS-WK26045MR IVTScrip™ mRNA-Human ATF2, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ATF2
GTTS-WK0622MR IVTScrip™ mRNA-Human ISLET-1, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ISLET-1
GTTS-WK3032MR IVTScrip™ mRNA-Human KLF4, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA KLF4
GTTS-WK5489MR IVTScrip™ mRNA-Human OCT3/4, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA OCT3/4
GTTS-WK4934MR IVTScrip™ mRNA-Human ATF4, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ATF4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →